Cancer and fungal diseases are two of the leading causes of death in the world. Current treatments for these diseases are reasonably effective, but are not always successful in curing patients. In addition, the medications used can cause serious side effects, increasing the patient’s physical and mental vulnerability throughout treatment.
New copper-based drugs with potent anti-tumor and anti-fungal activity.
Metallodrugs work to treat cancer and fungal diseases by binding to the DNA of diseased cells. They are more effective than current treatments and are less toxic to healthy cells, generating fewer side effects.
Patent title:
Phenolic binucleating ligands, binuclear metallic compounds, medical-veterinary composition, processes for synthesizing binucleating ligands, process for synthesizing binuclear compounds, method for treating neoplasms and fungal diseases and use
Deposit Number:
BR 10 2020 013240 7
Pontifical Catholic University of Rio de Janeiro – PUC-Rio
Rua Marquês de São Vicente, 225, Gávea
Rio de Janeiro, RJ – Brasil
Zip code: 22451-900
Postal box: 38097
Phone:
+55 (21) 3527-2155